Outlook Therapeutics, Inc. (OTLK): 8-K filed Sep 30, 2026

Form type

8-K

Filing date

Sep 30, 2026

Accession number

0001104659-26-112356

Filer

Outlook Therapeutics, Inc. (CIK 1649989)